Diffusion Pharmaceuticals Inc: Clinical Trials

6 trials sponsored by Diffusion Pharmaceuticals Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Terminated 1
Phase 23Completed 3

Follow Diffusion Pharmaceuticals Inc: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude
Trans Sodium Crocetinate - Healthy Volunteers With Induced Hypoxia
Phase 1CompletedDiffusion Pharmaceuticals Inc302021-11-092022-04-13
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers
Trans-Sodium Crocetinate, Placebo - Healthy Subjects
Phase 1CompletedDiffusion Pharmaceuticals Inc302021-03-172023-07-11
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19)
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc252020-09-102022-04-14
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
Trans Sodium Crocetinate (TSC) - Glioblastoma, GBM
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc592012-02-012017-07-14
Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma
Trans Sodium Crocetinate (TSC) - High Grade Glioma
Phase 1TerminatedDiffusion Pharmaceuticals Inc12009-03-012010-08-12
Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
Trans sodium crocetinate (TSC), 0.9% normal saline - Intermittent Claudication
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc482008-08-012011-07-29

Conditions studied

Brain Neoplasms (2)  ·  Glioma (2)  ·  Atherosclerosis (1)  ·  COVID-19 (1)  ·  Glioblastoma (1)  ·  Hypoxia (1)  ·  Intermittent Claudication (1)  ·  Peripheral Arterial Disease (1)

Interventions

trans-sodium crocetinate (6)  ·  Saline Solution (2)  ·  Sodium Chloride (2)

Countries

United States (5)  ·  Romania (1)

Top investigators

Adrian Streinu Cercel, MD (1)  ·  David R. Jones, M.D. (1)  ·  Martin K Kankam, MD, PhD (1)

Results publications

PMID 15758009, PMID 22003000, PMID 27177177